drugset / Trial / NCT03792958
Study of Challenge Meditech 082 (CM082) Tablets in Patients With Advanced Malignant Solid Tumors
NaSequentialOpen-labelTreatment
Summary
This is a Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Oral Dosing of CM082 tablets in Chinese Patients With Advanced Malignant Solid Tumors
Timeline
- Start
- 2019-02-26
- Primary completion
- 2023-06
- Completion
- 2023-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CM082 | Unknown | 200 mg | Oral |
| Subject | CM082 | Unknown | 400 mg | Oral |
| Subject | CM082 | Unknown | 600 mg | Oral |
| Subject | CM082 | Unknown | 800 mg | Oral |